Skip to main content
  • Investors
  • Mediaopen in a new window
  • Contact Usopen in a new window
  • |
Ironwood Logoopen in a new window
  • Company
  • Science & Medicine
  • Patients
  • Responsibility
  • Careers
  • IR Home
  • Why Invest
  • Events & Presentations
  • Corporate Governance
    • Governance Documents
    • Executive Management
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financials
    • Quarterly Results
    • Annual Reports
    • SEC Filings
  • Investor FAQs
  • Press Releases
  • Investor Contacts
    • Investor Emails Alerts
    • RSS Feeds
  • IR Home
  • Why Invest
  • Events & Presentations
  • Corporate Governance
    • Governance Documents
    • Executive Management
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financials
    • Quarterly Results
    • Annual Reports
    • SEC Filings
  • Investor FAQs
  • Press Releases
  • Investor Contacts
    • Investor Emails Alerts
    • RSS Feeds
Close
Close
  • Investors
  • Company
  • Product
  • Research & Development
  • Patients
  • Partnerships
  • Careers
Close

Press Releases

Normal
Press Release RSS Feed (opens in new window)
Press release year list 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
December 9, 2014
Ironwood Pharmaceuticals Initiates Phase IIa Clinical Study of IW-9179 in Diabetic Gastroparesis
Download PDF format download (opens in new window)
November 20, 2014
Ironwood Earns $15 Million Milestone from Astellas upon Initiation of Enrollment in Linaclotide Phase III IBS-C Clinical Trial in Japan
Download PDF format download (opens in new window)
November 5, 2014
Ironwood Pharmaceuticals to Present at Credit Suisse 2014 Healthcare Conference
Download PDF format download (opens in new window)
November 4, 2014
Ironwood Pharmaceuticals Initiates Phase III Trial of 72 mcg Linaclotide in Adult Patients with Chronic Idiopathic Constipation
Download PDF format download (opens in new window)
November 4, 2014
Ironwood Pharmaceuticals Provides Third Quarter 2014 Investor Update
Download PDF format download (opens in new window)
October 20, 2014
Ironwood Presents IW-9179 Phase IIa Data at American College of Gastroenterology 2014 Annual Scientific Meeting
Download PDF format download (opens in new window)
October 16, 2014
Ironwood Pharmaceuticals Announces Initiation of Phase II Trial of Linaclotide in Adult Patients with Opioid-Induced Constipation
Download PDF format download (opens in new window)
October 14, 2014
Ironwood Pharmaceuticals to Host Third Quarter 2014 Investor Update Call
Download PDF format download (opens in new window)
October 9, 2014
Ironwood and Actavis to Present Linaclotide Data at the American College of Gastroenterology 2014 Annual Scientific Meeting
Download PDF format download (opens in new window)
September 3, 2014
Ironwood Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
Download PDF format download (opens in new window)
September 2, 2014
Ironwood Appoints Two New Senior Executives to Support Continued Growth as a Leader in Gastroenterology
Download PDF format download (opens in new window)
August 4, 2014
Ironwood Pharmaceuticals Provides Second Quarter 2014 Investor Update
Download PDF format download (opens in new window)
July 7, 2014
Ironwood Pharmaceuticals to Host Second Quarter 2014 Investor Update Call
Download PDF format download (opens in new window)
June 5, 2014
Ironwood Pharmaceuticals to Present at Goldman Sachs Global Healthcare Conference
Download PDF format download (opens in new window)
June 4, 2014
Ironwood Pharmaceuticals Appoints Douglas Williams, Ph.D., to Board of Directors
Download PDF format download (opens in new window)
May 7, 2014
Ironwood Pharmaceuticals to Present at Bank of America Merrill Lynch 2014 Healthcare Conference
Download PDF format download (opens in new window)
May 1, 2014
Ironwood and Forest to Present Linaclotide Data at Digestive Disease Week® 2014
Download PDF format download (opens in new window)
April 29, 2014
Ironwood Pharmaceuticals Provides First Quarter 2014 Investor Update
Download PDF format download (opens in new window)
April 10, 2014
Ironwood and Forest Launch New Direct-to-Consumer Awareness Campaign For LINZESS®
Download PDF format download (opens in new window)
April 8, 2014
Ironwood Pharmaceuticals to Host First Quarter 2014 Investor Update Call
Download PDF format download (opens in new window)
March 18, 2014
Ironwood Pharmaceuticals Initiates Phase II Clinical Study of IW-3718 in Refractory Gastroesophageal Reflux Disease
Download PDF format download (opens in new window)
February 24, 2014
Ironwood Pharmaceuticals to Present at Cowen and Company 34th Annual Health Care Conference
Download PDF format download (opens in new window)
February 13, 2014
Ironwood Pharmaceuticals Announces Exercise of Underwriters' Option in Public Offering of Common Stock
Download PDF format download (opens in new window)
February 12, 2014
Ironwood Pharmaceuticals Appoints Julie McHugh to Board of Directors
Download PDF format download (opens in new window)
February 11, 2014
Ironwood Pharmaceuticals Prices Public Offering of Common Stock
Download PDF format download (opens in new window)
February 10, 2014
Ironwood Pharmaceuticals Announces Proposed Public Offering of Common Stock
Download PDF format download (opens in new window)
February 10, 2014
Ironwood Receives Notice of Allowance for Methods of Use Formulation Patent Expected to Extend LINZESS® Patent Protection Through 2031
Download PDF format download (opens in new window)
February 7, 2014
Ironwood Pharmaceuticals to Present at Leerink Global Healthcare Conference
Download PDF format download (opens in new window)
January 21, 2014
Ironwood Pharmaceuticals Provides Fourth Quarter 2013 Investor Update
Download PDF format download (opens in new window)
January 8, 2014
Ironwood Pharmaceuticals Announces Alignment of Workforce with Priority Growth Platforms
Download PDF format download (opens in new window)
January 7, 2014
Ironwood Pharmaceuticals to Host Fourth Quarter 2013 Investor Update Call
Download PDF format download (opens in new window)
January 6, 2014
Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Download PDF format download (opens in new window)

Investor Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Ironwood Pharmaceuticals, Inc., we strive to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Ironwood Pharmaceuticals, Inc. to send you the requested Investor Email Alert updates.

* Required

*
*





Email Alert Sign Up Confirmation

Ironwood Logoopen in a new window
  • Investors
  • Media
  • Contact us
Follow us on Linkedin Follow us on Twitter

COMPANY

  • Company Overview
  • Leadership
  • Open Payments & Transparecy

PRODUCT

  • Linzees

RESEARCH & DEVELOPMENT

  • Pipeline
  • Medical Affairs

PARTNERSHIPS

  • Overview
  • Grants

PATIENTS

  • Overview

RESPONSBILITY

  • Overview
  • Community Giving
  • Equity,Diversity & Inclusion
  • Sustainability
  • Safety & Compliance
  • Patients & Research

CAREERS

  • Working at Ironwood
  • Open Positions
  • Internships, Co-ops & Fellowships

INVESTORS

  • Home
  • Why Invest
  • Events & Presentations
  • Corporate Governance
  • Finanical Information
  • Investor FAQ
  • Press Releases
  • Investor Contacts
  • Copyright © Ironwood. All rights reserved Powered By Q4 Inc. 5.77.0.2 (opens in new window)
  • Privacy Policy
  • California Privacy Policy
  • Site Map
  • Terms of Use